Navigation Links
Beverly Hills Eye Surgeon Gets Surprise Inundation of Requests From Around the World for Information About New Treatment That Saved USA Bobsled Captain Steve Holcomb's Eyesight
Date:2/18/2010

BEVERLY HILLS, Calif., Feb. 18 /PRNewswire/ -- According to the Boxer Wachler Vision Institute, U.S. bobsled Capt. Steve Holcomb may do more than just bring home gold at the Vancouver 2010 Winter Olympics.  The story of how Holcomb went from going blind due to a degenerative eye condition called Keratoconus to having his vision restored with a breakthrough new medical procedure called C3-R is raising global awareness of the C3-R treatment.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100218/LA57563)

"Keratoconus can be a devastating condition, and it affects millions of people worldwide," says Dr. Brian Boxer Wachler of Beverly Hills, California, pioneer of the C3-R treatment.  "Keratoconus can take away from people the ability to read, to drive a car, and to just live a normal life.  When Steve first came to my office he was facing having to leave his sport because he could no longer see well enough to drive his bobsled downhill."

Holcomb's coaches and the USOC weren't ready to give up on their best driver.  They researched C3-R, then a relatively new procedure, and thought it was the best chance to save Holcomb's eyesight.  The USOC and the USA Bobsled and Skeleton Federation took the exceptional step of paying for Holcomb to have the treatment.

"Previously, the only treatment for severe Keratoconus was a cornea transplant," says Dr. Boxer Wachler.  "This is why C3-R is being seen as such a breakthrough.  C3-R is non-surgical.  It uses vitamin applications and light to strengthen the cornea. C3-R can cure the disease without the need for a cornea transplant.  The treatment only takes 30 minutes and can be done in a doctor's office."  

Dr. Boxer Wachler has successfully treated numerous Keratoconus patients with C3-R over the last six years.  Still, though, the global standard for the treatment of severe Keratoconus is a cornea transplant, an invasive surgery that is painful and carries the risk of rejection.

"It can be hard to get doctors to switch to a new procedure, especially one so radically different," says Dr. Boxer Wachler. "But now that is dramatically changing because of Steve.  Steve's story is making doctors and patients all over the world aware of C3-R."

Shortly after having his Keratoconus cured with C3-R and receiving insertable contacts to further improve his vision, Holcomb won the World Bobsled Championship -- the first U.S. medal in bobsled in 50 years.  Now, he is the USA's best hope for a gold medal in Bobsled at the  Vancouver 2010 Winter Olympics.

The news coverage of Holcomb's story, from legally blind to World Champion, has had an incredible surprise effect in raising awareness of C3-R.  Since the Olympic games began, the Boxer Wachler Vision Institute has been flooded with phone calls, emails, and letters from eye surgeons and patients all over the world wanting to know more about the C3-R treatment.  

"If this keeps up we are going to have to rename the procedure Holcomb C3-R," says Dr. Boxer Wachler.  "It's been an absolute miracle.  Steve's personal story has helped so many people by raising awareness of this new treatment."

About Dr. Brian Boxer Wachler:

Dr. Brian S. Boxer Wachler, MD is a world-renowned ophthalmologist, nationally and internationally admired for his expertise in Keratoconus treatments, LASIK and other vision correction procedures.  Dr. Boxer Wachler was named as one of "America's Top Doctors" by Castle Connolly this year.  He founded the Boxer Wachler Vision Institute in Beverly Hills, California to further research into new vision correction procedures and provide patients with the most advanced vision care treatments. He has served on the Board of Medical Directors of a non-profit Keratoconus Foundation and was Chairman of the Communications Committee for the Internal Society of Refractive Surgery. Because of his expertise, he is routinely invited to lecture worldwide on the latest advances in Keratoconus treatments, safety in refractive surgery, and other new refractive surgery innovations.  He has published over 65 peer-reviewed articles and book chapters in his field and is widely regarded as one of the world's best eye surgeons.

For media inquiries, please contact Tyler Barnett at 323.937.1951 or tyler@tylerbarnettpr.com. More information about C3-R can be found at www.KeratoconusInserts.com.

SOURCE Boxer Wachler Vision Institute

Back to top

RELATED LINKS
http://www.KeratoconusInserts.com

'/>"/>

SOURCE Boxer Wachler Vision Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Move Over Botox - Beverly Hills Simoni Plastic Surgery to Hold the First Ever Dysport Party
2. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
3. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
4. Terumo to Sponsor Presentations on Key Issues in Cardiac and Vascular Surgery at Society of Thoracic Surgeons Annual Meeting
5. Hand Surgeons Take Ethics into Their Own Hands
6. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
7. ATS Medical Products Featured Prominently at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting
8. PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress
9. A Unique Endoluminal Approach for the Treatment of Morbid Obesity Selected for Presentation at the 2009 American College of Surgeons Clinical Congress
10. Leading Trauma Surgeon Paints a Bleak Picture of U.S. Trauma System - Calls for Surgeons to Advocate for Systems Where Lacking
11. Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):